Premium
Quantitative Risk‐Benefit Analysis of A Calcium Channel Antagonist During Regulatory Review
Author(s) -
Nguyen B.,
Marroum P.J.,
Gobburu J.V.
Publication year - 2003
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1016/s0009-9236(03)90476-0
Subject(s) - antagonist , calcium channel , calcium , pharmacology , business , risk analysis (engineering) , medicine , receptor
Clinical Pharmacology & Therapeutics (2003) 73 , P33–P33; doi: